Minimal sizes of deletions detected by comparative genomic hybridization
✍ Scribed by Martin Bentz; Anja Plesch; Stephan Stilgenbauer; Hartmut Döhner; Peter Lichter
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 92 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Comparative genomic hybridization (CGH) has been used widely for the molecular cytogenetic analysis of tumors. Until now, the spatial resolution of this technique for diagnosing deletions of chromosomal sequences has not been assessed in detail. In the present study, we performed CGH analyses on five DNA samples derived from B-cell leukemias with 11q deletions, the sizes of which ranged from 3 Mbp to 14-18 Mbp. CGH experiments were evaluated by two established commercial analysis systems. Deletions down to a size of 10-12 Mbp were diagnosed based on a diagnostic threshold value of 0.8, if the vast majority of cells carried the deletion. For cases with smaller deletions, the ratio profiles were shifted toward underrepresentation at the respective chromosomal bands; however, the diagnostic threshold value was not reached. In all five cases, there was complete agreement between the two image analysis systems.
📜 SIMILAR VOLUMES
Comparative genomic hybridization (CGH) is a widely used technique for studying chromosomal imbalances. The sensitivity of the technique is, however, relatively low. Deletions down to a size of 10-12 Mbp have been detected by the use of fixed diagnostic thresholds. In this study, we applied standard
Familial occurrence of gliomas, in the absence of well-defined hereditary multisystem disorders, is reported occasionally. We describe 17 families that have been afflicted with two or more gliomas but do not raise suspicion of other inheritable syndromes. The families were identified among 369 conse
In our case, the absence of phenotypic abnormalities indicates that the supernumerary genes present in this de novo marker do not include those which are responsible for the high pathogenicity of chromosome 16 trisomy. It would be of interest to identify the loci present in this marker. This might h